SlideShare a Scribd company logo
A3H II EXPRESSED IN SF9 CELLS
GST affinity
purification
Optimization of the expression and purification of APOBEC3H
Maria Klarizza Panaligan, Karen Siu, Jeffrey E. Lee
Department of Laboratory Medicine & Pathobiology, University of Toronto
Introduction
A3H proteins are restriction factors that contribute to the
innate immune response against retroviruses, such as the
human immunodeficiency virus type 1 (HIV-1).
FUNCTION
• DNA cytidine
deaminase
that generate
C-to-U mutations
on the viral
(–) ssDNA strand
Rationale
The structure of A3H has not yet been solved, and little is known
of its haplotypes (II and VII) that are active against HIV-1. In our
study, we focused on isolating sufficient amounts of stable A3H
that will be useful for future downstream experiments.
Methods & Results
PROTEIN EXPRESSION AND PURIFICATION
• A3H forms inclusion bodies when expressed from E.coli
• Recombinant protein expression in Sf9 and S2 insect cells
• After PEI precipitation,
nanodrop 260/280 readings
dropped from ~1.51 to ~0.5
Discussion
Target Cell
C
A3H
C U
A
reverse
transcripted
(-) strand ssDNA
C-to-U deamination
by A3H
Deaminated
(-) ssDNA
(+) ssDNA
(G-to-A)
ANTAGONIST
• Antagonized by an HIV-1 protein called Vif
A3H +
Vif
• A3H can be expressed in S2 cells, but in lower
amounts compared to Sf9 cells
• PEI precipitation is an efficient method for removing
nucleic acid contaminants from A3H
• A3H becomes “sticky” and is difficult to elute from
the resin after removal of nucleic acids
Future Directions
• A260/280 readings indicate
nucleic acid contamination
in purified A3H II and VII
from both Sf9 and S2 cells.
• Needed to remove nucleic
acids in order to study A3H
• Intracellular expression of
A3H confirmed in S2 cells
(+) (+) media
A3H II and VII
from S2 cells
western blot
S2 cell
media
western blot
hap
II
hap
VII
ANTIVIRAL ACTIVITY
infected
cell
healthy
cell
• Hypermutates viral DNA, resulting in a genome that can no
longer be used for viral replication in the next host cell.
unsuccesful
infection
Human cells have developed multiple mechanisms to inhibit viral replication, and viruses
in turn have evolved diverse strategies to antagonize these efforts. Apolipoprotein B
mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) proteins are a key factor
in an intracellular defense strategy for inhibition of replication of HIV. While seven
haplotypes of APOBEC3H are present in humans, only haplotypes II, V and VII are active
against HIV-1. These haplotypes are packaged into newly assembled virions and induce
C-to-U mutations on the viral minus-strand DNA, which results in a hypermutated
genome that would be unable to infect the next target cell. HIV-1 disrupts this host
defense mechanism by encoding a viral infectivity factor (Vif) that effectively targets
APOBEC3 proteins for E3 ubiquitin ligase-mediated proteasomal degradation. Stable
APOBEC3H haplotypes have been shown to show some catalytic activity even in the
presence of Vif. The study of the HIV-1 Vif/APOBEC3 axis represents an attractive target
for HIV/AIDS research. Biochemical and high-resolution structural analysis of the
interplay between HIV-1 Vif, APOBEC3s and other cellular factors provide an integrated
approach to understand their function and to provide a master blueprint to design new
classes of HIV drugs that unleash the potent anti-viral activity of host innate immune
factors for AIDS prevention/therapy. Here, we present our preliminary work towards
expressing and purifying various full-length APOBEC3H haplotypes for future functional
and structural studies.
HIV-1 Vif
close-up
diagram
Abstract
Method A260/280
for A3H II
High salt washes
Benzonase + RNase A
treatment
PEI precipitation 0.5
1.52
1M NaCl
1M LiCl
2M NaBr
1.47
1.59
1.46
haplotype
# 15 18 105 121 178
I
II
III
IV
V
VI
VII
N R G K E
N R R D D
R R D D
L R D D
N R R D E
L G K D
N R R K E
anti-
HIV
activity
SF9/BACULOVIRUS DROSOPHILA S2
Method used virus infection transfection
Viability declines after
infection
constantly
high
Cell line
GST-affinity purification
GST
GSH
A3H
GST
A3H
GSH
GSHGST
+
thrombin
A3H
• A3H II and VII expressed in and purified from Sf9 cells
GST tag (~26kDa)
A3H+GST tag
(~48kDa)
REMOVING CONTAMINATING NUCLEIC ACID FROM A3HII
4.) Nucleic acid content was monitored through 260/280
NanoDrop 2000 readings
PEI
A3H
A3H
A3H
PEI
PEI
A3H
A3H
A3H
PEI
A3H
A3H
A3H
PEI
A3H A3H
A3H
+PEI
+non-saturating
ammonium
sulfate
rock 4C
for
20min
and spin
resuspend pellet
for dialysis and
GST
PURIFICATION
PROTOCOL
PEI
PEI
PEI
+ saturated
ammonium
sulfate
and spin
PEI
PEI
1.) High salt washes during GST-affinity purification.
2.) Benzonase and RNase A treatment
3.) PEI precipitation
A3H+
GST tag
A3H
PEI
1A1 1A2 1A3
Ion Exchange Chromatography
GST affinity purification
coomasie gel
A3HII
lysate
A3HII
beads
A3HVII
lysate
A3HVII
beads
MW
(kDa)
MW
(kDa)
1A1 1A2 1A3
1A1 1A2 1A3
A3H VII
Mono S run
A3H II
Mono S run
A3H II
size column run
Size Exclusion Chromatography
1A6-1A10
MW 1A61A71A81A91A10
1A1-1A8
1A1-
1A8
MW
(kDa)
A3H VII
size column run
1A1 1A2 1A3
BIOCHEMICAL PROFILE
• 7 haplotypes: I II III IV V VI VII
Ub
Ub
proteasomal
degradation
degraded
A3H
A3H
Ub
Vif
EloB
EloC
CUL5
RBX2 E2 Ub ACKNOWLEDGEMENTS:
Prof. Linda Chelico,
University of Saskatchewan
coomasie
gel
coomasie
gel
coomasie
gel coomasie
gel
thrombin-
cleaved
A3H
1) Search for additives or detergents that help stabilize A3H
after nucleic acid removal.
2) If insect cell expression remains unpromising, move on
to expressing in mammalian cells
2) Study the binding of A3H with ssDNA substrate
3) Study the binding of A3H with its viral antagonist, Vif
4) Understand the structure of A3H through X-ray
crystallography and other
biophysical methods
coomasie
gel
45
25
35
20
45
25
35
20
45
25
35
20
45
25
35
20
MW
(kDa)
45
25
35
20
45
25
35
20
45
25
35
20
45
25
35
20
(kDa)
MW
(kDa)

More Related Content

What's hot

Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sowsChapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Merial EMEA
 
Atherosclerosis: New Insights on Foamy Macrophage Induction and Persistence
Atherosclerosis: New Insights on Foamy Macrophage Induction and PersistenceAtherosclerosis: New Insights on Foamy Macrophage Induction and Persistence
Atherosclerosis: New Insights on Foamy Macrophage Induction and Persistence
Dr. Marian Laderoute
 
2009 conservation of hepatitis c virus nonstructural protein 3 amino acid seq...
2009 conservation of hepatitis c virus nonstructural protein 3 amino acid seq...2009 conservation of hepatitis c virus nonstructural protein 3 amino acid seq...
2009 conservation of hepatitis c virus nonstructural protein 3 amino acid seq...
Nádia Elizabeth Barbosa Villas Bôas
 
17
1717
In silico functional assignment to Rv3430c, a Mycobacterium tuberculosis gene...
In silico functional assignment to Rv3430c, a Mycobacterium tuberculosis gene...In silico functional assignment to Rv3430c, a Mycobacterium tuberculosis gene...
In silico functional assignment to Rv3430c, a Mycobacterium tuberculosis gene...
Rajni Chauhan
 
October 09 talk
October 09 talkOctober 09 talk
October 09 talk
Sky Lar
 
FINAL POSTER BIOTECH
FINAL POSTER BIOTECHFINAL POSTER BIOTECH
FINAL POSTER BIOTECHEmine Taytas
 
CCR5 Zincfinger
CCR5 ZincfingerCCR5 Zincfinger
CCR5 ZincfingerRyla Best
 
In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus
In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus
In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus Yordan Penev
 
Sigma xi presentation final1
Sigma xi presentation   final1Sigma xi presentation   final1
Sigma xi presentation final1mukta936
 
Expression Profiling of FasL Gene in Human Blood Tissues and its Correlation ...
Expression Profiling of FasL Gene in Human Blood Tissues and its Correlation ...Expression Profiling of FasL Gene in Human Blood Tissues and its Correlation ...
Expression Profiling of FasL Gene in Human Blood Tissues and its Correlation ...
SSR Institute of International Journal of Life Sciences
 

What's hot (20)

Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sowsChapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
 
Atherosclerosis: New Insights on Foamy Macrophage Induction and Persistence
Atherosclerosis: New Insights on Foamy Macrophage Induction and PersistenceAtherosclerosis: New Insights on Foamy Macrophage Induction and Persistence
Atherosclerosis: New Insights on Foamy Macrophage Induction and Persistence
 
2009 conservation of hepatitis c virus nonstructural protein 3 amino acid seq...
2009 conservation of hepatitis c virus nonstructural protein 3 amino acid seq...2009 conservation of hepatitis c virus nonstructural protein 3 amino acid seq...
2009 conservation of hepatitis c virus nonstructural protein 3 amino acid seq...
 
ISMB2010_Poster
ISMB2010_PosterISMB2010_Poster
ISMB2010_Poster
 
Cancer Research 2
Cancer Research 2Cancer Research 2
Cancer Research 2
 
17
1717
17
 
HHMI Poster Final
HHMI Poster FinalHHMI Poster Final
HHMI Poster Final
 
GKA deel 2 college 3
GKA deel 2 college 3GKA deel 2 college 3
GKA deel 2 college 3
 
Kira's poster Final
Kira's poster FinalKira's poster Final
Kira's poster Final
 
In silico functional assignment to Rv3430c, a Mycobacterium tuberculosis gene...
In silico functional assignment to Rv3430c, a Mycobacterium tuberculosis gene...In silico functional assignment to Rv3430c, a Mycobacterium tuberculosis gene...
In silico functional assignment to Rv3430c, a Mycobacterium tuberculosis gene...
 
GKA deel 2 college 10
GKA deel 2 college 10GKA deel 2 college 10
GKA deel 2 college 10
 
IGEM poster
IGEM posterIGEM poster
IGEM poster
 
October 09 talk
October 09 talkOctober 09 talk
October 09 talk
 
1-s2.0-S0167488913002401-main
1-s2.0-S0167488913002401-main1-s2.0-S0167488913002401-main
1-s2.0-S0167488913002401-main
 
FINAL POSTER BIOTECH
FINAL POSTER BIOTECHFINAL POSTER BIOTECH
FINAL POSTER BIOTECH
 
CCR5 Zincfinger
CCR5 ZincfingerCCR5 Zincfinger
CCR5 Zincfinger
 
In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus
In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus
In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus
 
1
11
1
 
Sigma xi presentation final1
Sigma xi presentation   final1Sigma xi presentation   final1
Sigma xi presentation final1
 
Expression Profiling of FasL Gene in Human Blood Tissues and its Correlation ...
Expression Profiling of FasL Gene in Human Blood Tissues and its Correlation ...Expression Profiling of FasL Gene in Human Blood Tissues and its Correlation ...
Expression Profiling of FasL Gene in Human Blood Tissues and its Correlation ...
 

Viewers also liked

Funny questions for couples to ask each other
Funny questions for couples to ask each otherFunny questions for couples to ask each other
Funny questions for couples to ask each other
Marriage Counseling Questions To Strengthen Your Relationship
 
Brain teasing questions 2
Brain teasing questions 2Brain teasing questions 2
Brain teasing questions 2
Silam Barasan
 
Funny questions
Funny questionsFunny questions
Funny questions
Sarwan Singh
 
Animal Riddles.
 Animal Riddles. Animal Riddles.
Animal Riddles.
Dian Fadhilawati
 
Funny quiz
Funny quizFunny quiz
Funny quizSanja .
 
Thinking Riddles
Thinking RiddlesThinking Riddles
Thinking Riddles
OH TEIK BIN
 
10 Tricky Riddles For The Young
10 Tricky Riddles For The Young10 Tricky Riddles For The Young
10 Tricky Riddles For The Young
OH TEIK BIN
 

Viewers also liked (9)

Puzzle design
Puzzle designPuzzle design
Puzzle design
 
Funny questions for couples to ask each other
Funny questions for couples to ask each otherFunny questions for couples to ask each other
Funny questions for couples to ask each other
 
Brain teasing questions 2
Brain teasing questions 2Brain teasing questions 2
Brain teasing questions 2
 
Funny questions
Funny questionsFunny questions
Funny questions
 
Animal Riddles.
 Animal Riddles. Animal Riddles.
Animal Riddles.
 
A fun filled quiz
A fun filled quizA fun filled quiz
A fun filled quiz
 
Funny quiz
Funny quizFunny quiz
Funny quiz
 
Thinking Riddles
Thinking RiddlesThinking Riddles
Thinking Riddles
 
10 Tricky Riddles For The Young
10 Tricky Riddles For The Young10 Tricky Riddles For The Young
10 Tricky Riddles For The Young
 

Similar to POSTER-MARIA KLARIZZA PANALIGAN

In vitro transcription and transfection of HCV genomic replicon
In vitro transcription and transfection of HCV genomic repliconIn vitro transcription and transfection of HCV genomic replicon
In vitro transcription and transfection of HCV genomic replicon
BinodGupta27
 
In vitro transcription and transfection of HCV genomic replicon
In vitro transcription and transfection of HCV genomic repliconIn vitro transcription and transfection of HCV genomic replicon
In vitro transcription and transfection of HCV genomic replicon
BinodGupta27
 
Deshpande et al. Retrovirology (2016)
Deshpande et al. Retrovirology (2016)Deshpande et al. Retrovirology (2016)
Deshpande et al. Retrovirology (2016)SHILPA PATIL
 
Seminario biomol
Seminario biomolSeminario biomol
Seminario biomol
Lala Duque
 
Seminario biología molecular. Juan camilo Botero
Seminario biología molecular. Juan camilo BoteroSeminario biología molecular. Juan camilo Botero
Seminario biología molecular. Juan camilo Botero
Camilo Botero
 
Directed evolution of a recombinase that excises the provirus of most HIV-1 p...
Directed evolution of a recombinase that excises the provirus of most HIV-1 p...Directed evolution of a recombinase that excises the provirus of most HIV-1 p...
Directed evolution of a recombinase that excises the provirus of most HIV-1 p...Carola Schäfer
 
Antimicrobial Agents and Chemotherapy 2003 47(8)2674-2681
Antimicrobial Agents and Chemotherapy 2003 47(8)2674-2681Antimicrobial Agents and Chemotherapy 2003 47(8)2674-2681
Antimicrobial Agents and Chemotherapy 2003 47(8)2674-2681Dinesh Barawkar
 
J. Virol.-2013-Maqbool-5523-39
J. Virol.-2013-Maqbool-5523-39J. Virol.-2013-Maqbool-5523-39
J. Virol.-2013-Maqbool-5523-39mimach
 
Zakir hcv
Zakir hcvZakir hcv
Zakir hcv
Kazi Zakir Zak
 
Deshpande S et al DST RETROVIROLOGY_b 2016
Deshpande S et al DST RETROVIROLOGY_b 2016Deshpande S et al DST RETROVIROLOGY_b 2016
Deshpande S et al DST RETROVIROLOGY_b 2016Suprit Deshpande, Ph.D.,
 
Deshpande S et al RETROVIROLOGY_b 2016
Deshpande S et al RETROVIROLOGY_b 2016Deshpande S et al RETROVIROLOGY_b 2016
Deshpande S et al RETROVIROLOGY_b 2016SHILPA PATIL
 
Poster_Epitope_mapping_of_persisting_EBV_infection_01
Poster_Epitope_mapping_of_persisting_EBV_infection_01Poster_Epitope_mapping_of_persisting_EBV_infection_01
Poster_Epitope_mapping_of_persisting_EBV_infection_01Paul Von Hoegen
 
Seminario Biología Molecular- Laura Rivera.pdf
Seminario Biología Molecular- Laura Rivera.pdfSeminario Biología Molecular- Laura Rivera.pdf
Seminario Biología Molecular- Laura Rivera.pdf
LauraTatiana21
 
HCV Overview Boceprevir & Thiazolides JES_mod062116
HCV Overview Boceprevir & Thiazolides JES_mod062116HCV Overview Boceprevir & Thiazolides JES_mod062116
HCV Overview Boceprevir & Thiazolides JES_mod062116J. Edward Semple
 
HIV Therapeutic vaccines
HIV Therapeutic vaccinesHIV Therapeutic vaccines
HIV Therapeutic vaccines
reza mozafari
 
AMPLIFICATION OF rpoB, kat G & mab A (fab G1)- inh A PROMOTOR DNA SEQUENCES B...
AMPLIFICATION OF rpoB, kat G & mab A (fab G1)- inh A PROMOTOR DNA SEQUENCES B...AMPLIFICATION OF rpoB, kat G & mab A (fab G1)- inh A PROMOTOR DNA SEQUENCES B...
AMPLIFICATION OF rpoB, kat G & mab A (fab G1)- inh A PROMOTOR DNA SEQUENCES B...
SSR Institute of International Journal of Life Sciences
 

Similar to POSTER-MARIA KLARIZZA PANALIGAN (20)

In vitro transcription and transfection of HCV genomic replicon
In vitro transcription and transfection of HCV genomic repliconIn vitro transcription and transfection of HCV genomic replicon
In vitro transcription and transfection of HCV genomic replicon
 
In vitro transcription and transfection of HCV genomic replicon
In vitro transcription and transfection of HCV genomic repliconIn vitro transcription and transfection of HCV genomic replicon
In vitro transcription and transfection of HCV genomic replicon
 
Deshpande et al. Retrovirology (2016)
Deshpande et al. Retrovirology (2016)Deshpande et al. Retrovirology (2016)
Deshpande et al. Retrovirology (2016)
 
Deshpande et al.,Retrovirology 2016
Deshpande et al.,Retrovirology 2016Deshpande et al.,Retrovirology 2016
Deshpande et al.,Retrovirology 2016
 
Seminario biomol
Seminario biomolSeminario biomol
Seminario biomol
 
Seminario biología molecular. Juan camilo Botero
Seminario biología molecular. Juan camilo BoteroSeminario biología molecular. Juan camilo Botero
Seminario biología molecular. Juan camilo Botero
 
Directed evolution of a recombinase that excises the provirus of most HIV-1 p...
Directed evolution of a recombinase that excises the provirus of most HIV-1 p...Directed evolution of a recombinase that excises the provirus of most HIV-1 p...
Directed evolution of a recombinase that excises the provirus of most HIV-1 p...
 
rli60 project FINAL
rli60 project FINALrli60 project FINAL
rli60 project FINAL
 
abbas morovvati
abbas morovvatiabbas morovvati
abbas morovvati
 
Antimicrobial Agents and Chemotherapy 2003 47(8)2674-2681
Antimicrobial Agents and Chemotherapy 2003 47(8)2674-2681Antimicrobial Agents and Chemotherapy 2003 47(8)2674-2681
Antimicrobial Agents and Chemotherapy 2003 47(8)2674-2681
 
J. Virol.-2013-Maqbool-5523-39
J. Virol.-2013-Maqbool-5523-39J. Virol.-2013-Maqbool-5523-39
J. Virol.-2013-Maqbool-5523-39
 
Abbas morovvati
Abbas morovvatiAbbas morovvati
Abbas morovvati
 
Zakir hcv
Zakir hcvZakir hcv
Zakir hcv
 
Deshpande S et al DST RETROVIROLOGY_b 2016
Deshpande S et al DST RETROVIROLOGY_b 2016Deshpande S et al DST RETROVIROLOGY_b 2016
Deshpande S et al DST RETROVIROLOGY_b 2016
 
Deshpande S et al RETROVIROLOGY_b 2016
Deshpande S et al RETROVIROLOGY_b 2016Deshpande S et al RETROVIROLOGY_b 2016
Deshpande S et al RETROVIROLOGY_b 2016
 
Poster_Epitope_mapping_of_persisting_EBV_infection_01
Poster_Epitope_mapping_of_persisting_EBV_infection_01Poster_Epitope_mapping_of_persisting_EBV_infection_01
Poster_Epitope_mapping_of_persisting_EBV_infection_01
 
Seminario Biología Molecular- Laura Rivera.pdf
Seminario Biología Molecular- Laura Rivera.pdfSeminario Biología Molecular- Laura Rivera.pdf
Seminario Biología Molecular- Laura Rivera.pdf
 
HCV Overview Boceprevir & Thiazolides JES_mod062116
HCV Overview Boceprevir & Thiazolides JES_mod062116HCV Overview Boceprevir & Thiazolides JES_mod062116
HCV Overview Boceprevir & Thiazolides JES_mod062116
 
HIV Therapeutic vaccines
HIV Therapeutic vaccinesHIV Therapeutic vaccines
HIV Therapeutic vaccines
 
AMPLIFICATION OF rpoB, kat G & mab A (fab G1)- inh A PROMOTOR DNA SEQUENCES B...
AMPLIFICATION OF rpoB, kat G & mab A (fab G1)- inh A PROMOTOR DNA SEQUENCES B...AMPLIFICATION OF rpoB, kat G & mab A (fab G1)- inh A PROMOTOR DNA SEQUENCES B...
AMPLIFICATION OF rpoB, kat G & mab A (fab G1)- inh A PROMOTOR DNA SEQUENCES B...
 

POSTER-MARIA KLARIZZA PANALIGAN

  • 1. A3H II EXPRESSED IN SF9 CELLS GST affinity purification Optimization of the expression and purification of APOBEC3H Maria Klarizza Panaligan, Karen Siu, Jeffrey E. Lee Department of Laboratory Medicine & Pathobiology, University of Toronto Introduction A3H proteins are restriction factors that contribute to the innate immune response against retroviruses, such as the human immunodeficiency virus type 1 (HIV-1). FUNCTION • DNA cytidine deaminase that generate C-to-U mutations on the viral (–) ssDNA strand Rationale The structure of A3H has not yet been solved, and little is known of its haplotypes (II and VII) that are active against HIV-1. In our study, we focused on isolating sufficient amounts of stable A3H that will be useful for future downstream experiments. Methods & Results PROTEIN EXPRESSION AND PURIFICATION • A3H forms inclusion bodies when expressed from E.coli • Recombinant protein expression in Sf9 and S2 insect cells • After PEI precipitation, nanodrop 260/280 readings dropped from ~1.51 to ~0.5 Discussion Target Cell C A3H C U A reverse transcripted (-) strand ssDNA C-to-U deamination by A3H Deaminated (-) ssDNA (+) ssDNA (G-to-A) ANTAGONIST • Antagonized by an HIV-1 protein called Vif A3H + Vif • A3H can be expressed in S2 cells, but in lower amounts compared to Sf9 cells • PEI precipitation is an efficient method for removing nucleic acid contaminants from A3H • A3H becomes “sticky” and is difficult to elute from the resin after removal of nucleic acids Future Directions • A260/280 readings indicate nucleic acid contamination in purified A3H II and VII from both Sf9 and S2 cells. • Needed to remove nucleic acids in order to study A3H • Intracellular expression of A3H confirmed in S2 cells (+) (+) media A3H II and VII from S2 cells western blot S2 cell media western blot hap II hap VII ANTIVIRAL ACTIVITY infected cell healthy cell • Hypermutates viral DNA, resulting in a genome that can no longer be used for viral replication in the next host cell. unsuccesful infection Human cells have developed multiple mechanisms to inhibit viral replication, and viruses in turn have evolved diverse strategies to antagonize these efforts. Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) proteins are a key factor in an intracellular defense strategy for inhibition of replication of HIV. While seven haplotypes of APOBEC3H are present in humans, only haplotypes II, V and VII are active against HIV-1. These haplotypes are packaged into newly assembled virions and induce C-to-U mutations on the viral minus-strand DNA, which results in a hypermutated genome that would be unable to infect the next target cell. HIV-1 disrupts this host defense mechanism by encoding a viral infectivity factor (Vif) that effectively targets APOBEC3 proteins for E3 ubiquitin ligase-mediated proteasomal degradation. Stable APOBEC3H haplotypes have been shown to show some catalytic activity even in the presence of Vif. The study of the HIV-1 Vif/APOBEC3 axis represents an attractive target for HIV/AIDS research. Biochemical and high-resolution structural analysis of the interplay between HIV-1 Vif, APOBEC3s and other cellular factors provide an integrated approach to understand their function and to provide a master blueprint to design new classes of HIV drugs that unleash the potent anti-viral activity of host innate immune factors for AIDS prevention/therapy. Here, we present our preliminary work towards expressing and purifying various full-length APOBEC3H haplotypes for future functional and structural studies. HIV-1 Vif close-up diagram Abstract Method A260/280 for A3H II High salt washes Benzonase + RNase A treatment PEI precipitation 0.5 1.52 1M NaCl 1M LiCl 2M NaBr 1.47 1.59 1.46 haplotype # 15 18 105 121 178 I II III IV V VI VII N R G K E N R R D D R R D D L R D D N R R D E L G K D N R R K E anti- HIV activity SF9/BACULOVIRUS DROSOPHILA S2 Method used virus infection transfection Viability declines after infection constantly high Cell line GST-affinity purification GST GSH A3H GST A3H GSH GSHGST + thrombin A3H • A3H II and VII expressed in and purified from Sf9 cells GST tag (~26kDa) A3H+GST tag (~48kDa) REMOVING CONTAMINATING NUCLEIC ACID FROM A3HII 4.) Nucleic acid content was monitored through 260/280 NanoDrop 2000 readings PEI A3H A3H A3H PEI PEI A3H A3H A3H PEI A3H A3H A3H PEI A3H A3H A3H +PEI +non-saturating ammonium sulfate rock 4C for 20min and spin resuspend pellet for dialysis and GST PURIFICATION PROTOCOL PEI PEI PEI + saturated ammonium sulfate and spin PEI PEI 1.) High salt washes during GST-affinity purification. 2.) Benzonase and RNase A treatment 3.) PEI precipitation A3H+ GST tag A3H PEI 1A1 1A2 1A3 Ion Exchange Chromatography GST affinity purification coomasie gel A3HII lysate A3HII beads A3HVII lysate A3HVII beads MW (kDa) MW (kDa) 1A1 1A2 1A3 1A1 1A2 1A3 A3H VII Mono S run A3H II Mono S run A3H II size column run Size Exclusion Chromatography 1A6-1A10 MW 1A61A71A81A91A10 1A1-1A8 1A1- 1A8 MW (kDa) A3H VII size column run 1A1 1A2 1A3 BIOCHEMICAL PROFILE • 7 haplotypes: I II III IV V VI VII Ub Ub proteasomal degradation degraded A3H A3H Ub Vif EloB EloC CUL5 RBX2 E2 Ub ACKNOWLEDGEMENTS: Prof. Linda Chelico, University of Saskatchewan coomasie gel coomasie gel coomasie gel coomasie gel thrombin- cleaved A3H 1) Search for additives or detergents that help stabilize A3H after nucleic acid removal. 2) If insect cell expression remains unpromising, move on to expressing in mammalian cells 2) Study the binding of A3H with ssDNA substrate 3) Study the binding of A3H with its viral antagonist, Vif 4) Understand the structure of A3H through X-ray crystallography and other biophysical methods coomasie gel 45 25 35 20 45 25 35 20 45 25 35 20 45 25 35 20 MW (kDa) 45 25 35 20 45 25 35 20 45 25 35 20 45 25 35 20 (kDa) MW (kDa)